Company intelligence / Profile preview

Azumio

Palo Alto, California, United Statesazumio.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Azumio has released a suite of popular mobile health applications focused on biometric data collection, wellness motivation, nutrition analysis using AI, and digital biomarkers for conditions like Type 2 Diabetes. Its flagship app Argus has been used in large-scale studies of physical activity worldwide. The company collaborates with leading academic institutions to validate its technologies[1][3].

Therapeutic areas: EndocrinologyOther
Modalities: Device (mobile applications)Non-pharmacological therapy (digital biomarkers, behavior modification)
Industry: Digital Health Medical Devices

Partnerships

Collaborations with Stanford University and University of California San Franciscopartnerships with industry players in mobile health sector

Beyond the preview

Go deeper on Azumio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azumio.

Explore the full profile